BRPI0722095A2 - Derivados de amina e seu uso em doenças mediadas por beta-2-adrenor-receptor - Google Patents
Derivados de amina e seu uso em doenças mediadas por beta-2-adrenor-receptorInfo
- Publication number
- BRPI0722095A2 BRPI0722095A2 BRPI0722095-2A2A BRPI0722095A BRPI0722095A2 BR PI0722095 A2 BRPI0722095 A2 BR PI0722095A2 BR PI0722095 A BRPI0722095 A BR PI0722095A BR PI0722095 A2 BRPI0722095 A2 BR PI0722095A2
- Authority
- BR
- Brazil
- Prior art keywords
- adrenor
- beta
- mediated diseases
- amine derivatives
- receptor mediated
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87095606P | 2006-12-20 | 2006-12-20 | |
| PCT/GB2007/004859 WO2008075025A1 (en) | 2006-12-20 | 2007-12-19 | Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0722095A2 true BRPI0722095A2 (pt) | 2014-04-01 |
Family
ID=39048968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0722095-2A2A BRPI0722095A2 (pt) | 2006-12-20 | 2007-12-19 | Derivados de amina e seu uso em doenças mediadas por beta-2-adrenor-receptor |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20120142646A1 (pt) |
| EP (1) | EP2094646A1 (pt) |
| JP (1) | JP2010513439A (pt) |
| KR (1) | KR20090094149A (pt) |
| CN (1) | CN101636379A (pt) |
| AR (1) | AR064636A1 (pt) |
| AU (1) | AU2007336074B2 (pt) |
| BR (1) | BRPI0722095A2 (pt) |
| CA (1) | CA2672792A1 (pt) |
| CL (1) | CL2007003754A1 (pt) |
| CO (1) | CO6210822A2 (pt) |
| EC (1) | ECSP099425A (pt) |
| MX (1) | MX2009006010A (pt) |
| NO (1) | NO20092690L (pt) |
| PE (1) | PE20081388A1 (pt) |
| RU (1) | RU2472783C2 (pt) |
| TW (1) | TW200835686A (pt) |
| UY (1) | UY30811A1 (pt) |
| WO (1) | WO2008075025A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| HRP20120968T1 (hr) | 2008-02-06 | 2013-01-31 | Astrazeneca Ab | Spojevi |
| WO2009154557A1 (en) * | 2008-06-18 | 2009-12-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| AU2009260904A1 (en) * | 2008-06-20 | 2009-12-23 | Astrazeneca Ab | Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity |
| GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
| WO2011048409A1 (en) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| US9598381B2 (en) * | 2014-07-31 | 2017-03-21 | Abbvie Inc. | SMYD2 inhibitors |
| CN107188865B (zh) * | 2016-03-14 | 2019-08-27 | 益方生物科技(上海)有限公司 | 苯并噁嗪化合物及其制备方法和用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2653977A (en) * | 1953-09-29 | Chxnx | ||
| DE3476196D1 (en) * | 1983-01-21 | 1989-02-23 | Fisons Plc | Aromatic amines |
| US5648370A (en) * | 1990-11-20 | 1997-07-15 | Astra Pharmaceuticals Limited | 7-(2-aminoethyl) benzothiazolones |
| GB9210632D0 (en) * | 1992-05-19 | 1992-07-01 | Fisons Plc | Compounds |
| TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
| US7217722B2 (en) * | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| GB0217225D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| TW200738658A (en) * | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
| TW200745084A (en) * | 2006-03-08 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
-
2007
- 2007-12-19 CA CA002672792A patent/CA2672792A1/en not_active Abandoned
- 2007-12-19 UY UY30811A patent/UY30811A1/es unknown
- 2007-12-19 TW TW096148621A patent/TW200835686A/zh unknown
- 2007-12-19 BR BRPI0722095-2A2A patent/BRPI0722095A2/pt not_active IP Right Cessation
- 2007-12-19 US US11/959,735 patent/US20120142646A1/en not_active Abandoned
- 2007-12-19 RU RU2009119912/04A patent/RU2472783C2/ru not_active IP Right Cessation
- 2007-12-19 JP JP2009542201A patent/JP2010513439A/ja not_active Withdrawn
- 2007-12-19 US US12/519,591 patent/US20100056508A1/en not_active Abandoned
- 2007-12-19 MX MX2009006010A patent/MX2009006010A/es active IP Right Grant
- 2007-12-19 WO PCT/GB2007/004859 patent/WO2008075025A1/en not_active Ceased
- 2007-12-19 EP EP07848596A patent/EP2094646A1/en not_active Withdrawn
- 2007-12-19 AU AU2007336074A patent/AU2007336074B2/en not_active Ceased
- 2007-12-19 CN CN200780051580A patent/CN101636379A/zh active Pending
- 2007-12-19 KR KR1020097015072A patent/KR20090094149A/ko not_active Withdrawn
- 2007-12-20 CL CL200703754A patent/CL2007003754A1/es unknown
- 2007-12-20 AR ARP070105802A patent/AR064636A1/es not_active Application Discontinuation
-
2008
- 2008-01-02 PE PE2008000006A patent/PE20081388A1/es not_active Application Discontinuation
-
2009
- 2009-05-27 CO CO09054436A patent/CO6210822A2/es not_active Application Discontinuation
- 2009-06-15 EC EC2009009425A patent/ECSP099425A/es unknown
- 2009-07-15 NO NO20092690A patent/NO20092690L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009006010A (es) | 2009-06-16 |
| RU2009119912A (ru) | 2011-01-27 |
| AU2007336074A1 (en) | 2008-06-26 |
| US20120142646A1 (en) | 2012-06-07 |
| CL2007003754A1 (es) | 2008-08-22 |
| AU2007336074B2 (en) | 2011-09-22 |
| WO2008075025A1 (en) | 2008-06-26 |
| CO6210822A2 (es) | 2010-10-20 |
| CN101636379A (zh) | 2010-01-27 |
| AR064636A1 (es) | 2009-04-15 |
| EP2094646A1 (en) | 2009-09-02 |
| UY30811A1 (es) | 2008-07-31 |
| US20100056508A1 (en) | 2010-03-04 |
| TW200835686A (en) | 2008-09-01 |
| KR20090094149A (ko) | 2009-09-03 |
| RU2472783C2 (ru) | 2013-01-20 |
| JP2010513439A (ja) | 2010-04-30 |
| PE20081388A1 (es) | 2008-11-26 |
| CA2672792A1 (en) | 2008-06-26 |
| NO20092690L (no) | 2009-09-03 |
| ECSP099425A (es) | 2009-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0722095A2 (pt) | Derivados de amina e seu uso em doenças mediadas por beta-2-adrenor-receptor | |
| DK1984322T3 (da) | Benzamid- og heteroarenderivater | |
| BRPI0814267A2 (pt) | Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico. | |
| BRPI0814963A2 (pt) | Pró-fármacos de dipeptóides e seu uso | |
| BRPI0821027A2 (pt) | 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso | |
| DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
| BRPI0716300A2 (pt) | Artigo e mistura | |
| BRPI0816372A2 (pt) | Ácidos 6-fenilnicotínicos substituídos e seu uso | |
| BRPI1008045A2 (pt) | derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia | |
| BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
| SI3424932T1 (sl) | Boronoftalidi za terapevtsko uporabo | |
| BRPI1010282A2 (pt) | polímeros aminados e seu uso em composições de origem aquosa | |
| PL2502938T3 (pl) | Przeciwciała i immunokoniugaty oraz ich zastosowanie | |
| BRPI0719345A2 (pt) | Di-hidroimidazóis substituídos e seu uso no tratamento de tumores. | |
| PL2468290T3 (pl) | Antagoniści aktywiny-ActRII do stosowania w leczeniu niedokrwistości | |
| BRPI0908225A2 (pt) | derivados de piridazina e seu uso como agentes terapêuticos | |
| BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
| BRPI0718137A2 (pt) | Comutadores moleculares e métodos para seu uso | |
| BRPI0813683A2 (pt) | composto amina e uso farmacêutico do mesmo | |
| DK2007884T3 (da) | Cellulasefusionsproteiner og deres anvendelse | |
| BRPI0813263A2 (pt) | Oxazolidinonas substituídas e seu uso | |
| BRPI0719923A2 (pt) | Nucleotídeos e nucleosídeos rotulados fotocliváveis e nucleotídeos e nucleosídeos rotulados e métodos para seu uso no sequenciamento de dna | |
| CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
| BRPI0716327A2 (pt) | Composto de fenilpropionamida e uso | |
| EP2054319A4 (en) | DISPENSER FOR WATTETAMPONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2285 DE 21/10/2014. |